Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01368055 · ClinicalTrials.gov registry record · NA
Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 361
- Enrollment target
NCT01368055 is a NA study that has completed, run by University of Florida. The registered enrollment target is 361 participants.
The verdict
NCT01368055, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
Study Summary
The purpose of this trial is to give a shorter course (5 ½-6 weeks) of proton radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of proton radiation, without decreasing the chance of killing prostate cancer cells.
Interventions
- RADIATION 70 Gy/CGE
- RADIATION 72.5 Gy/CGE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2011-09 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01368055
The ClinicalTrials.gov registry entry for NCT01368055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 70 Gy/CGE is the first listed.
NCT01368055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01368055 about?
NCT01368055 is a clinical study titled "Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer". The purpose of this trial is to give a shorter course (5 ½-6 weeks) of proton radiation that has as little side effects on normal bladder and rectal tissues as the usual longer course (8 weeks) of proton radiation, without decreasing the chance of killing prostate cancer cells.
What is the current status of trial NCT01368055?
This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2011-09. Estimated completion is 2025-08.
What interventions are being tested in trial NCT01368055?
The interventions under investigation include: 70 Gy/CGE (RADIATION), 72.5 Gy/CGE (RADIATION).
Who is sponsoring clinical trial NCT01368055?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.